Trending Insights
Frequently Asked Questions
-
What value is the immuno-oncology market market expected to touch by 2033?
The global immuno-oncology market market is expected to USD 2.05 billion by 2033.
-
What CAGR is the immuno-oncology market market expected to exhibit during forecast period?
The immuno-oncology market market is expected to exhibit a CAGR of 4.5% over forecast period.
-
Which are the driving factors of the immuno-oncology market?
Increasing demand for immune checkpoint inhibitors are the driving factor of the immuno-oncology market.
-
Which are the top companies operating in the immuno-oncology market?
Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon pharmaceuticals are the top operating companies in the immuno-oncology market.